TerminatedNCT04262193
Dual-Orexin Antagonism As a Mechanism for Improving Sleep and Drug Abstinence in Addiction
Medication studyAges 18–70United States
Understand this study
Who could participate?
Listed age limits: 18 years to 70 years.
- Listed locations
- DetroitSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: February 1, 2021
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 37
- Sponsor
- Wayne State University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT04262193
- Official title
Show the full official title
Dual-Orexin Antagonism As a Mechanism for Improving Sleep and Drug Abstinence in Opioid Use Disorder
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Detroit
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Wayne State University, a university.
Does this study involve medication?
Yes. The study involves medication, including Suvorexant and Suvorexant Placebo.
Who can participate?
Listed age limits: 18 years to 70 years.
Is this study still recruiting?
The registry lists this study as terminated.
